Tolerance, Xenotransplantation: Future Therapies

Surgical Clinics of North America

Volumn 86, Issue 5, 2006, Pages 1277-1296

  Weiss, Matthew J ^a   Ng, Choo Y ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; HEPARIN; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ALLOGRAFT; BONE MARROW TRANSPLANTATION; CHIMERA; CHRONIC GRAFT REJECTION; CLINICAL PROTOCOL; FUTUROLOGY; GRAFT SURVIVAL; HEMATOPOIESIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; INFECTION COMPLICATION; INFECTION SENSITIVITY; MALIGNANT NEOPLASTIC DISEASE; MYELOABLATIVE CONDITIONING; NONHUMAN; ORGAN DONOR; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; REVIEW; SURVIVAL TIME; SWINE; THYMUS TRANSPLANTATION; TRANSGENIC ANIMAL; TRANSPLANTATION TOLERANCE; WHOLE BODY RADIATION; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; GRAFT REJECTION; HUMANS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 33748320843     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.06.016     Document Type: Review

References (86)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23 (2004) 796-803
2. Merion R.M. Preface: 2003 SRTR Report on the State of Transplantation. Am J Transplant 4 Suppl 9 (2004) 5-6
3. Billingham R.E., Brent L., and Medawar P.B. Actively acquired tolerance to foreign cells. Nature 172 (1953) 603-606
4. Auchincloss Jr. H. In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance. Am J Transplant 1 (2001) 6-12
5. Spitzer T.R., Delmonico F., Tolkoff-Rubin N., et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68 (1999) 480-484
6. Buhler L.H., Spitzer T.R., Sykes M., et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74 (2002) 1405-1409
7. Waldmann H., Graca L., Cobbold S., et al. Regulatory T cells and organ transplantation. Semin Immunol 16 (2004) 119-126
8. Wekerle T., and Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation 68 (1999) 459-467
9. Ildstad S.T., and Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307 (1984) 168-170
10. Kawai T., Cosimi A.B., Colvin R.B., et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59 (1995) 256-262
11. Wekerle T., and Sykes M. Induction of tolerance. Surgery 135 (2004) 359-364
12. Kawai T., Sachs D.H., and Cosimi A.B. Tolerance to vascularized organ allografts in large-animal models. Curr Opin Immunol 11 (1999) 516-520
13. Hoffmann M.W., Allison J., and Miller J.F.A.P. Tolerance induction by thymic medullary epithelium. Proc Natl Acad Sci USA 89 (1992) 2526-2530
14. Waer M., Palathumpat V., Sobis H., et al. Induction of transplantation tolerance in mice across major histocompatibility barrier by using allogeneic thymus transplantation and total lymphoid irradiation. J Immunol 145 (1990) 499-504
15. Haller G.W., Esnaola N., Yamada K., et al. Thymic transplantation across an MHC class I barrier in swine. J Immunol 163 (1999) 3785-3792
16. Yamada K., Shimizu A., Ierino F.L., et al. Thymic transplantation in miniature swine. I. Development and function of the "thymokidney". Transplantation 68 (1999) 1684-1692
17. Lambrigts D., Menard M.T., Alexandre G.P.J., et al. Creation of the "thymoheart" allograft: implantation of autologous thymus into the heart prior to procurement. Transplantation 66 (1998) 810-814
18. Yamada K., Shimizu A., Utsugi R., et al. Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients. J Immunol 164 (2000) 3079-3086
19. Menard M.T., Schwarze M.L., Allan J.S., et al. Composite "thymoheart" transplantation improves cardiac allograft survival. Am J Transplant 4 (2004) 79-86
20. LaMattina J.C., Kumagai N., Barth R.N., et al. Vascularized thymic lobe transplantation in miniature swine. I. Vascularized thymic lobe allografts support thymopoiesis. Transplantation 73 (2002) 826-831
21. Johnston D.R., Muniappan A., Hoerbelt R., et al. Heart and en-bloc thymus transplantation in miniature swine. J Thorac Cardiovasc Surg 130 (2005) 554-559
22. Kamano C., Vagefi P.A., Kumagai N., et al. Vascularized thymic lobe transplantation in miniature swine: thymopoiesis and tolerance induction across fully MHC-mismatched barriers. Proc Natl Acad Sci USA 101 (2004) 3827-3832
23. Nobori S., Samelson-Jones E., Shimizu A., et al. Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. Transplantation 81 (2006) 26-35
24. UNOS. Waiting list data: 2001. United Network for Organ Sharing 2001. Available at: http://www.unos.org. Accessed April 2006.
25. Cooper D.K.C., Keogh A.M., Brink J., et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 19 (2000) 1125-1165
26. Yamada K., Griesemer A., and Okumi M. Pigs as xenogenic donors. Transplant Rev 19 (2005) 164-177
27. Pratschke J., Wilhelm M.J., Kusaka M., et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 67 (1999) 343-348
28. Laskowski I., Pratschke J., Wilhelm M.J., et al. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 5 (2000) 29-35
29. Sykes M., and Sachs D.H. Mixed chimerism. Philos Trans R Soc Lond B Biol Sci 356 (2001) 707-726
30. Bracy J.L., Sachs D.H., and Iacomini J. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 281 (1998) 1845-1847
31. Salama A.D., Delikouras A., Pusey C.D., et al. Transplant accommodation in highly sensitized patients: a potential role of Bcl-xL and alloantibody. Am J Transplant 1 (2001) 260-269
32. Hajjar R.J., del Monte F., Matsui T., et al. Prospects for gene therapy for heart failure. Circ Res 86 (2000) 616-621
33. Sachs D.H. MHC homozygous miniature swine. In: Swindle M.M., Moody D.C., and Phillips L.D. (Eds). Swine as models in biomedical research (1992), Iowa State University Press, Ames (IA) 3-15
34. Sachs D.H. The pig as a potential xenograft donor. Pathol Biol 42 (1994) 217-228
35. Allan J.S., Rose G.A., Choo J.K., et al. Morphometric analysis of miniature swine hearts as potential human xenografts. Xenotransplantation 8 (2001) 90-93
36. Fishman J.A. Infection and xenotransplantation: developing strategies to minimize risk. Ann N Y Acad Sci 862 (1998) 52-66
37. Good A.H., Cooper D.K.C., Malcolm A.J., et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 24 (1992) 559-562
38. Cooper D.K.C., Good A.H., Koren E., et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1 (1993) 198-205
39. Galili U., Macher B.A., Buehler J., et al. Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1-3) linked galactose residues. J Exp Med 162 (1985) 573-582
40. Galili U., Rachmilewitz E.A., Peleg A., et al. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med 160 (1984) 1519-1531
41. Dalmasso A.P., Vercelolotti G.M., Platt J.L., et al. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation 52 (1991) 530-533
42. Cozzi E., and White D.J.G. The generation of transgenic pigs as potential organs donors for humans. Nat Med 1 (1995) 964-966
43. Schmoeckel M., Nollert G., Shahmohammadi M., et al. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 62 (1996) 729-734
44. Cozzi E., Yannoutsos N., Langford G.A., et al. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. In: Cooper D.K.C., Kemp E., Platt J.L., et al. (Eds). Xenotransplantation (1997), Springer-Verlag, Heidelberg 665-682
45. Bhatti F.N., Schmoeckel M., Zaidi A., et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc 31 (1999) 958
46. Vial C.M., Ostlie D.J., Bhatti F.N., et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 19 2 (2000) 224-229
47. Schmoeckel M., Bhatti F.N.K., Zaidi A., et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 65 (1998) 1570-1577
48. Kuwaki K., Knosalla C., Dor F.J.M.F., et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant 4 3 (2004) 363-372
49. Byrne G.W., McCurry K.R., Martin M.J., et al. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63 (1997) 149-155
50. McGregor C.G., Teotia S.S., Schirmer J.M., et al. Advances in preclinical cardiac xenotransplantation. J Heart Lung Transplant 22 (2003) S89
51. McGregor C.G., Davies W.R., Oi K., et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 130 (2005) 844-851
52. Cooper D.K.C., Koren E., and Oriol R. Genetically engineered pigs. Lancet 342 (1993) 682-683
53. Dai Y., Vaught T.D., Boone J., et al. Targeted disruption of the alpha-1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20 (2002) 251-255
54. Lai L., Kolber-Simonds D., Park K.W., et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295 (2002) 1089-1092
55. Kolber-Simonds D., Lai L., Watt S.R., et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 101 (2004) 7335-7340
56. Yamada K., Yazawa K., Shimizu A., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha-1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11 (2005) 32-34
57. Kuwaki K., Tseng Y.L., Dor F.J., et al. Heart transplantation in baboons using alpha-1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29-31
58. Schroeder C., Allan J.S., Nguyen B.-N., et al. Hyperacute rejection is attenuated in GalT-KO swine lungs perfused ex vivo with human blood. Transplant Proc 37 1 (2005) 512-513
59. Zaidi A., Schmoeckel M., Bhatti F., et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65 (1998) 1584-1590
60. Dorling A., and Lechler R.I. T cell-mediated xenograft rejection: specific tolerance is probably required for long term xenograft survival. Xenotransplantation 5 (1998) 234-245
61. Sachs D.H., Sykes M., Robson S.C., et al. Xenotransplantation. In: Dixon F.J. (Ed). Advances in immunology (2001), Academic Press, San Diego 129-233
62. Buhler L., Awwad M., Basker M., et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 69 (2000) 2296-2304
63. Alexandre G.P.J., Squifflet J.P., deBruyere M., et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 19 (1987) 4538
64. Sachs D.H., and Sablinski T. Tolerance across discordant xenogeneic barriers. Xenotransplantation 2 (1995) 234-239
65. Latinne D., Smith C.V., Nickeleit V., et al. Xenotransplantation from pig to cynomolgus monkey: approach toward tolerance induction. Transplant Proc 25 (1993) 336
66. Tanaka M., Latinne D., Sablinski T., et al. Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism. Transplant Proc 26 (1994) 1326
67. Sablinski T., Latinne D., Bailin M., et al. Xenotransplantation of pig kidneys to nonhuman primates. I. Development of the model. Xenotransplantation 2 (1995) 264-270
68. Sachs D.H., Sykes M., Greenstein J., et al. Tolerance and xenograft survival. Nat Med 1 9 (1995) 969
69. Xu Y., Lorf T., Sablinski T., et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column. Transplantation 65 (1998) 172-179
70. Kozlowski T., Fuchimoto Y., Monroy R., et al. Apheresis and column absorption for specific removal of Gal-alpha-1, 3 Gal natural antibodies in a pig-to-baboon model. Transplant Proc 29 (1997) 961
71. Buhler L., Awwad M., Treter S., et al. Induction of mixed hematopoietic chimerism in the pig-to-baboon model. Transplant Proc 32 (2000) 1101
72. Buhler L., Basker M., Alwayn I.P., et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 70 (2000) 1323-1331
73. Lee L.A., Gritsch H.A., Sergio J.J., et al. Specific tolerance across a discordant xenogeneic transplantation barrier. Proc Natl Acad Sci USA 91 (1994) 10864-10867
74. Zhao Y., Fishman J.A., Sergio J.J., et al. Immune restoration by fetal pig thymus grafts in T cell-depleted, thymectomized mice. J Immunol 158 (1997) 1641-1649
75. Zhao Y., Swenson K., Sergio J.J., et al. Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 2 (1996) 1211-1216
76. Wu A., Yamada K., Awwad M., et al. Effects of xenogeneic thymic transplantation in baboons. Transplant Proc 33 (2001) 766
77. Wu A., Yamada K., Awwad M., et al. Experience with porcine thymic transplantation in baboons. Transplant Proc 32 (2000) 1048
78. Bach F.H., and Fineberg H.V. Call for moratorium on xenotransplants. Nature 391 (1998) 326
79. Sachs D.H., Colvin R.B., Cosimi A.B., et al. Xenotransplantation-caution, but no moratorium. Nat Med 4 (1998) 372-373
80. Stoye J.P., and Coffin J.M. The dangers of xenotransplantation. Nat Med 1 (1995) 1100
81. Patience C., Takeuchi Y., and Weiss R.A. Zoonosis in xenotransplantation. Curr Opin Immunol 10 (1998) 539-542
82. Patience C., Takeuchi Y., and Weiss R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3 (1997) 282-286
83. Paradis K., Langford G., Long Z., et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue: the XEN 111 Study Group. Science 285 (1999) 1236-1241
84. Cooper D.K., Keogh A.M., Brink J., et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 19 (2000) 1125-1165
85. Onions D., Cooper D.K., Alexander T.J., et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation 7 (2000) 143-155
86. Fishman J.A. Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology. Kidney Int Suppl 58 (1997) S41-S45